Computer-aid drug design, synthesis, and anticoagulant activity evaluation of novel dabigatran derivatives as thrombin inhibitors
Authors:
- 1 September 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 137, 104965
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (19ZR1455400)
This publication has 28 references indexed in Scilit:
- Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 InhibitorsChemMedChem, 2017
- Antithrombotic drugs marketNature Reviews Drug Discovery, 2014
- Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidanceHeart, 2012
- Mechanisms of platelet activation by thrombin: A short historyThrombosis Research, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Dabigatran etexilate: A novel oral direct thrombin inhibitorAmerican Journal of Health-System Pharmacy, 2011
- Dabigatran etexilateNature Reviews Drug Discovery, 2008
- The central role of thrombin in hemostasisJournal of Thrombosis and Haemostasis, 2007
- Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic EnzymesThrombosis and Haemostasis, 1998
- Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding timeBritish Journal of Pharmacology, 1994